Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Nifty recovers 200 points from intra-day lows; IT continues outperformance | Closing Bell
Indian equities erased all the intraday losses with Nifty back above 23,500. TCS, Infosys, HCL Tech, Tech Mahindra, Trent are among top gainers on the Nifty, while losers are NTPC, Power Grid Corp, Cipla, Dr Reddy's Labs and L&T. Among sectors IT index up 4%, while auto, metal, Consumer Durables, realty up 0.5% each. However, pharma, healthcare, power, media, energy down 0.5-1%. Nifty Midcap and Smallcap indices down marginally. Catch Lovish Darad in conversation with Market Experts.
Taking Stock: Nifty reclaims 23,400, Sensex ends 304 pts lower; IT drags
Among sectors, IT index shed 5.5%, FMCG, realty slipped 1% each, and Consumer Durables fell 0.8%, while Telecom index rose 2%, PSU Bank index jumped 1.7%, healthcare index was up 0.5% each.
Taking Stock: Nifty below 24,200, Sensex slips 516 pts amid global tensions; IT stocks shine
Among sectors, except IT, Healthcare, Consumer Durables and FMCG, all other indices ended in the red with PSU Bank index slipped 3%, Oil & Gas index shed 1%, while Private Bank, Metal, Energy, Power, Realty down 0.5% each.
Neutral Blue Star; target of Rs 1920: Motilal Oswal
Motilal Oswal recommended Neutral rating on Blue Star with a target price of Rs 1920 in its research report dated May 07, 2026.
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.
Live: Nifty logs second weekly loss; rupee rebounds 80 paise | Closing Bell
Indian equities traded lower on Friday afternoon as weakness in metal and information technology stocks outweighed gains in select financial, healthcare and consumer names. At 2:18 pm, the Sensex was down 299.98 points or 0.40 percent at 74,060.03, while the Nifty slipped 110.15 points or 0.47 percent to 23,306.40. Market breadth remained weak, with 2,070 stocks declining against 1,720 advances. The Nifty Metal index dropped nearly 2 percent and Nifty IT fell over 1 percent, while broader markets also underperformed. However, the Nifty Media index surged more than 2 percent and realty stocks traded higher, offering some support. Catch Lovish Darad in conversation with Market Experts.
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.
Taking Stock: Sensex, Nifty slip in volatile trade after RBI policy; banking stocks outperform
Among sectors, Media index gained 3.5%, while PSU Banks, Realty, Consumer Durables, and Healthcare rose 0.5% each. In contrast, Energy, IT, Metal, Oil & Gas, and Telecom indices declined between 0.5% and 1.5%.
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.